Existing biologics such as Canakinumab (monoclonal antibody), Anakinra (monoclonal antibody) and Rilonacept (fusion protein) can be exploited as therapeutics that restrain inflammation in COVID-19...
Researchers have adapted living cells and created novel living machines. Called xenobot, these are not a new species of animals but pure artefacts, designed...
The discovery of a new type of malleable, self-healing and completely recyclable "electronic skin” has wide applications in health monitoring, robotics, prosthetics and improved...